|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5000 CAD | 0.00% |
|
-1.96% | +9.89% |
| 06-03 | PharmaCorp Rx Initiated at Outperform, $0.70 Price Target at Raymond James | MT |
| 06-01 | Earnings Flash (PCRX.V) PharmaCorp Reports Q1 Revenue $7.2M, Up 79.4% YoY | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
Drug Stores and Pharmacies | |||||
Wholly Owned Pharmacies | - | - | - | 2.8M | 14.66M |
Gross Profit | - | - | - | 1.04M | 5.7M |
Operating Income | - | - | - | 316K | 1.84M |
Non-wholly Owned Pharmacies | - | - | - | 2.99M | 6.24M |
Total Assets | 1M | 2.73M | 2.32M | - | - |
EBT | -25.82K | -517K | -470K | - | - |
Gross Profit | - | - | - | 1.14M | 2.6M |
Operating Income | - | - | - | 205K | 653K |
Net Income | -25.82K | -517K | -470K | - | - |
Operating Income | - | - | - | -2.12M | -3.79M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
Canada | - | - | - | 5.79M | 20.89M |
Total Assets | 1M | 2.73M | 2.32M | 35.21M | 65.57M |
Interest Expense | - | - | - | -14.26K | -56.86K |
Income Tax Expense | - | - | - | -106K | 586K |
D&A | - | - | - | 290K | 940K |
CAPEX | - | - | - | -6.89K | -87.6K |
Gross Profit | - | - | - | 2.18M | 8.3M |
Net Income | -25.82K | -517K | -470K | -1.01M | -1.48M |
EBT | -25.82K | -517K | -470K | -1.16M | -836K |
Operating Income | - | - | - | -1.6M | -1.29M |
- Stock Market
- Stocks
- PCRX Stock
- Financials PharmaCorp Rx Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
